登入 Remember me (Uncheck if on a shared computer) Forgot your Password ? Please review the fields marked in red and resubmit the form 註冊 成為新會員 Register to access independent medical news and resources from Univadis®
Medical News Advance care planning linked with longer survival in terminally ill patients Univadis Medical News Friday 13 December 2019 The effects are strongest among those with diseases other than cancer. Cancer risk in patients with atopic dermatitis Univadis Medical News Friday 13 December 2019 Evidence suggests potential associations between atopic dermatitis and both increased and decreased cancer risks. New platform to review unpublished studies Univadis Medical News Friday 13 December 2019 The platform will expedite submission to 17 affiliate journals. More Medical News > Conference Reports SABCS 2019 – Add-on capecitabine effective in early TNBC Univadis Monday 16 December 2019 Results of subset from >15,000 patient meta-analysis of (neo)adjuvant capecitabine. SABCS 2019 – Adding S-1 to endocrine treatment improves survival in HR+, HER2− breast cancer Univadis Friday 13 December 2019 Japanese phase 3 POTENT trial reported 39% reduction in disease recurrence. SABCS 2019 – HER2+ breast cancer: add-on pertuzumab shows clinically relevant benefit in some patients Univadis Friday 13 December 2019 4.5% increase in invasive DFS in node-positive subgroup did not meet significance but still relevant. More Conference Reports >
Medical News Advance care planning linked with longer survival in terminally ill patients Univadis Medical News Friday 13 December 2019 The effects are strongest among those with diseases other than cancer. Cancer risk in patients with atopic dermatitis Univadis Medical News Friday 13 December 2019 Evidence suggests potential associations between atopic dermatitis and both increased and decreased cancer risks. New platform to review unpublished studies Univadis Medical News Friday 13 December 2019 The platform will expedite submission to 17 affiliate journals. More Medical News >
Conference Reports SABCS 2019 – Add-on capecitabine effective in early TNBC Univadis Monday 16 December 2019 Results of subset from >15,000 patient meta-analysis of (neo)adjuvant capecitabine. SABCS 2019 – Adding S-1 to endocrine treatment improves survival in HR+, HER2− breast cancer Univadis Friday 13 December 2019 Japanese phase 3 POTENT trial reported 39% reduction in disease recurrence. SABCS 2019 – HER2+ breast cancer: add-on pertuzumab shows clinically relevant benefit in some patients Univadis Friday 13 December 2019 4.5% increase in invasive DFS in node-positive subgroup did not meet significance but still relevant. More Conference Reports >
Featured channels Oncology Oncology essentials all in one place Zika All you need to know about Zika virus